echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Hormone levels before and after menopause are associated with the risk of invasive breast cancer

    Br J Cancer: Hormone levels before and after menopause are associated with the risk of invasive breast cancer

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Breast cancer is one of the most common cancers in women worldwide, and it is hormone-dependent.
    In postmenopausal women, hormone replacement therapy and obesity increase the risk of breast cancer.

    Breast cancer is one of the most common cancers among women in the world, and it is hormone-dependent.
    Breast cancer is one of the most common cancers among women in the world, and it is hormone-dependent.
    Breast cancer

    Previous studies have shown that certain endogenous hormones can play a vital role in cancer by promoting cell proliferation and increasing the risk of random genetic errors.
    Some endogenous hormones have been confirmed to be related to the risk of breast cancer, but the essence of these relationships is not fully understood.

    Certain endogenous hormones can play a vital role in cancer by promoting cell proliferation and increasing the risk of random genetic errors.
    Certain endogenous hormones can play a vital role in cancer by promoting cell proliferation and increasing the risk of random genetic errors.

    In this study, the researchers measured the hormone concentrations in serum collected by the UK Biobank during 2006–2010 and repeated sub-samples (N≈5000) collected during 2012–13, and linked the data Identify sudden cancers.
    The study aims to assess the relationship between the levels of various hormones and the risk of breast cancer.

    The study aims to assess the relationship between the levels of various hormones and the risk of breast cancer.
    The study aims to assess the relationship between the levels of various hormones and the risk of breast cancer.

    Correlation between hormone and SHBG levels in premenopausal women and the risk of invasive breast cancer

    Correlation between hormone and SHBG levels in premenopausal women and the risk of invasive breast cancer

    The results showed that during the median follow-up time of 7.
    1 years, 527 and 2,997 of 30,565 premenopausal women and 133,294 postmenopausal women were diagnosed with invasive breast cancer, respectively.
    Researchers found that the risk of cancer in postmenopausal women was positively correlated with testosterone levels, while there was no correlation in premenopausal women.

    diagnosis

    The average concentration of total estradiol in each stage of the menstrual cycle in premenopausal women

    The average concentration of total estradiol in each stage of the menstrual cycle in premenopausal women

    Further research has shown that the risk of cancer is positively correlated with the level of IGF-1 (insulin-like growth factor 1) and negatively correlated with SHBG (sex hormone binding globulin).
    It is only in premenopausal women that estradiol has nothing to do with the risk of disease, but there are still few studies on this hormone.


    All in all, this study confirmed that testosterone, IGF-1 and SHBG are related to the risk of breast cancer, and that the heterogeneity due to menopausal status is related to testosterone.


    This study confirmed that testosterone, IGF-1 and SHBG are related to the risk of breast cancer, and that the heterogeneity due to menopausal status is related to testosterone.


    This study confirmed that testosterone, IGF-1 and SHBG are related to the risk of breast cancer, and that the heterogeneity due to menopausal status is related to testosterone.



    org/10.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.